Biological and clinical significance of anti-Müllerian hormone determination in blood serum of the mare

J. Almeida, B. A. Ball, Alan J Conley, N. J. Place, Irwin Liu, E. L. Scholtz, L. Mathewson, Scott D Stanley, Benjamin Moeller

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Anti-Müllerian hormone (AMH), a member of the transforming growth factor β superfamily of growth and differentiation factors, is expressed in granulosa cells of preantral and small antral ovarian follicles. In humans, AMH appeared to regulate recruitment and growth of small ovarian follicles. Furthermore, circulating AMH concentrations were elevated in women with granulosa-cell tumors (GCT). In the horse, GCTs are the most common tumor of the ovary, and a variety of endocrine assays have been used to diagnose presumptive GCTs. The objectives of the present study were to validate a heterologous enzyme immunoassay for determination of serum AMH in the horse, and to determine concentrations of AMH in the blood of mares during the estrous cycle, pregnancy, and in mares with granulosa-cell tumors. Mares with normal estrous cycles (n = 6) and pregnant mares (n = 6) had blood samples collected throughout one interovulatory period and monthly throughout gestation, respectively. Mares diagnosed with GCT had blood samples taken before (n = 11) and after ovariectomy (n = 5). Tumors were sectioned and fixed for immunohistochemistry and snap frozen for immunoblot analyses and RT-qPCR. In normal cyclic mares and in pregnant mares, there was no effect of cycle stage or month of gestation on serum AMH concentrations. In GCT mares, serum concentrations of AMH (1901.4 ± 1144.6 ng/mL) were higher than those in cyclic (0.96 ± 0.08 ng/mL) or pregnant (0.72 ± 0.05 ng/mL) mares and decreased after tumor removal. Both AMH and AMH receptor (AMHR2) immunolabeling and expression were detected by immunohistochemistry in the tumor and cyst fluid obtained from mares with GCTs. Therefore, we concluded that AMH was a useful biomarker for detection of granulosa-cell tumors in mares.

Original languageEnglish (US)
Pages (from-to)1393-1403
Number of pages11
JournalTheriogenology
Volume76
Issue number8
DOIs
StatePublished - Nov 2011

Fingerprint

blood serum
mares
hormones
Hormones
Granulosa Cell Tumor
granulosa cells
Serum
neoplasms
Ovarian Follicle
Estrous Cycle
ovarian follicles
pregnancy
Pregnancy
Horses
estrous cycle
Neoplasms
immunohistochemistry
blood
Immunohistochemistry
Growth Differentiation Factors

Keywords

  • Anti-Müllerian hormone
  • Equine estrous cycle
  • Granulosa-cell tumor
  • Ovarian follicle
  • Ovary
  • Pregnancy

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Equine
  • Food Animals
  • Small Animals

Cite this

Biological and clinical significance of anti-Müllerian hormone determination in blood serum of the mare. / Almeida, J.; Ball, B. A.; Conley, Alan J; Place, N. J.; Liu, Irwin; Scholtz, E. L.; Mathewson, L.; Stanley, Scott D; Moeller, Benjamin.

In: Theriogenology, Vol. 76, No. 8, 11.2011, p. 1393-1403.

Research output: Contribution to journalArticle

@article{b811e92cd60542ab8bf1174870fcffb6,
title = "Biological and clinical significance of anti-M{\"u}llerian hormone determination in blood serum of the mare",
abstract = "Anti-M{\"u}llerian hormone (AMH), a member of the transforming growth factor β superfamily of growth and differentiation factors, is expressed in granulosa cells of preantral and small antral ovarian follicles. In humans, AMH appeared to regulate recruitment and growth of small ovarian follicles. Furthermore, circulating AMH concentrations were elevated in women with granulosa-cell tumors (GCT). In the horse, GCTs are the most common tumor of the ovary, and a variety of endocrine assays have been used to diagnose presumptive GCTs. The objectives of the present study were to validate a heterologous enzyme immunoassay for determination of serum AMH in the horse, and to determine concentrations of AMH in the blood of mares during the estrous cycle, pregnancy, and in mares with granulosa-cell tumors. Mares with normal estrous cycles (n = 6) and pregnant mares (n = 6) had blood samples collected throughout one interovulatory period and monthly throughout gestation, respectively. Mares diagnosed with GCT had blood samples taken before (n = 11) and after ovariectomy (n = 5). Tumors were sectioned and fixed for immunohistochemistry and snap frozen for immunoblot analyses and RT-qPCR. In normal cyclic mares and in pregnant mares, there was no effect of cycle stage or month of gestation on serum AMH concentrations. In GCT mares, serum concentrations of AMH (1901.4 ± 1144.6 ng/mL) were higher than those in cyclic (0.96 ± 0.08 ng/mL) or pregnant (0.72 ± 0.05 ng/mL) mares and decreased after tumor removal. Both AMH and AMH receptor (AMHR2) immunolabeling and expression were detected by immunohistochemistry in the tumor and cyst fluid obtained from mares with GCTs. Therefore, we concluded that AMH was a useful biomarker for detection of granulosa-cell tumors in mares.",
keywords = "Anti-M{\"u}llerian hormone, Equine estrous cycle, Granulosa-cell tumor, Ovarian follicle, Ovary, Pregnancy",
author = "J. Almeida and Ball, {B. A.} and Conley, {Alan J} and Place, {N. J.} and Irwin Liu and Scholtz, {E. L.} and L. Mathewson and Stanley, {Scott D} and Benjamin Moeller",
year = "2011",
month = "11",
doi = "10.1016/j.theriogenology.2011.06.008",
language = "English (US)",
volume = "76",
pages = "1393--1403",
journal = "Theriogenology",
issn = "0093-691X",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Biological and clinical significance of anti-Müllerian hormone determination in blood serum of the mare

AU - Almeida, J.

AU - Ball, B. A.

AU - Conley, Alan J

AU - Place, N. J.

AU - Liu, Irwin

AU - Scholtz, E. L.

AU - Mathewson, L.

AU - Stanley, Scott D

AU - Moeller, Benjamin

PY - 2011/11

Y1 - 2011/11

N2 - Anti-Müllerian hormone (AMH), a member of the transforming growth factor β superfamily of growth and differentiation factors, is expressed in granulosa cells of preantral and small antral ovarian follicles. In humans, AMH appeared to regulate recruitment and growth of small ovarian follicles. Furthermore, circulating AMH concentrations were elevated in women with granulosa-cell tumors (GCT). In the horse, GCTs are the most common tumor of the ovary, and a variety of endocrine assays have been used to diagnose presumptive GCTs. The objectives of the present study were to validate a heterologous enzyme immunoassay for determination of serum AMH in the horse, and to determine concentrations of AMH in the blood of mares during the estrous cycle, pregnancy, and in mares with granulosa-cell tumors. Mares with normal estrous cycles (n = 6) and pregnant mares (n = 6) had blood samples collected throughout one interovulatory period and monthly throughout gestation, respectively. Mares diagnosed with GCT had blood samples taken before (n = 11) and after ovariectomy (n = 5). Tumors were sectioned and fixed for immunohistochemistry and snap frozen for immunoblot analyses and RT-qPCR. In normal cyclic mares and in pregnant mares, there was no effect of cycle stage or month of gestation on serum AMH concentrations. In GCT mares, serum concentrations of AMH (1901.4 ± 1144.6 ng/mL) were higher than those in cyclic (0.96 ± 0.08 ng/mL) or pregnant (0.72 ± 0.05 ng/mL) mares and decreased after tumor removal. Both AMH and AMH receptor (AMHR2) immunolabeling and expression were detected by immunohistochemistry in the tumor and cyst fluid obtained from mares with GCTs. Therefore, we concluded that AMH was a useful biomarker for detection of granulosa-cell tumors in mares.

AB - Anti-Müllerian hormone (AMH), a member of the transforming growth factor β superfamily of growth and differentiation factors, is expressed in granulosa cells of preantral and small antral ovarian follicles. In humans, AMH appeared to regulate recruitment and growth of small ovarian follicles. Furthermore, circulating AMH concentrations were elevated in women with granulosa-cell tumors (GCT). In the horse, GCTs are the most common tumor of the ovary, and a variety of endocrine assays have been used to diagnose presumptive GCTs. The objectives of the present study were to validate a heterologous enzyme immunoassay for determination of serum AMH in the horse, and to determine concentrations of AMH in the blood of mares during the estrous cycle, pregnancy, and in mares with granulosa-cell tumors. Mares with normal estrous cycles (n = 6) and pregnant mares (n = 6) had blood samples collected throughout one interovulatory period and monthly throughout gestation, respectively. Mares diagnosed with GCT had blood samples taken before (n = 11) and after ovariectomy (n = 5). Tumors were sectioned and fixed for immunohistochemistry and snap frozen for immunoblot analyses and RT-qPCR. In normal cyclic mares and in pregnant mares, there was no effect of cycle stage or month of gestation on serum AMH concentrations. In GCT mares, serum concentrations of AMH (1901.4 ± 1144.6 ng/mL) were higher than those in cyclic (0.96 ± 0.08 ng/mL) or pregnant (0.72 ± 0.05 ng/mL) mares and decreased after tumor removal. Both AMH and AMH receptor (AMHR2) immunolabeling and expression were detected by immunohistochemistry in the tumor and cyst fluid obtained from mares with GCTs. Therefore, we concluded that AMH was a useful biomarker for detection of granulosa-cell tumors in mares.

KW - Anti-Müllerian hormone

KW - Equine estrous cycle

KW - Granulosa-cell tumor

KW - Ovarian follicle

KW - Ovary

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=80053561911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053561911&partnerID=8YFLogxK

U2 - 10.1016/j.theriogenology.2011.06.008

DO - 10.1016/j.theriogenology.2011.06.008

M3 - Article

VL - 76

SP - 1393

EP - 1403

JO - Theriogenology

JF - Theriogenology

SN - 0093-691X

IS - 8

ER -